1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cytomegalovirus viral load kinetics predict cytomegalovirus end-organ disease and mortality after hematopoietic cell transplant
    Journal Article

    Stern, A.; Su, Y.; Dumke, H.; Fang, J.; Tamari, R.; Jakubowski, A.; Cho, C.; Giralt, S.; Perales, M. A.; Papanicolaou, G. A.
    Journal of Infectious Diseases (2021)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors in patients with pre-existing psoriasis: Safety and efficacy
    Journal Article

    Halle, B. R.; Betof Warner, A.; Zaman, F. Y.; Haydon, A.; Bhave, P.; Dewan, A. K.; Ye, F.; Irlmeier, R.; Mehta, P.; Kurtansky, N. R.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Acute lymphoblastic leukemia, version 2.2021: NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Brown, P. A.; Shah, B.; Advani, A.; Aoun, P.; Boyer, M. W.; Burke, P. W.; DeAngelo, D. J.; Dinner, S.; Fathi, A. T.; Gauthier, J.; more...
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness
    Journal Article

    Hirschhorn, D.; Betof Warner, A.; Maniyar, R.; Chow, A.; Mangarin, L. M. B.; Cohen, A. D.; Hamadene, L.; Rizzuto, G. A.; Budhu, S.; Suek, N.; more...
    JCI Insight (2021)

    Fulltext@MSK | Save
  • Progress in understanding the biology of nodular lymphocyte-predominant Hodgkin lymphoma
    Editorial

    Straus, D. J.
    Haematologica (2021)

    Fulltext@MSK | Save
  • Comparative mutational profiling of hematopoietic progenitor cells and circulating endothelial cells (CECs) in patients with primary myelofibrosis
    Journal Article

    Farina, M.; Bernardi, S.; Polverelli, N.; D’Adda, M.; Malagola, M.; Bosio, K.; Re, F.; Almici, C.; Dunbar, A.; Levine, R. L.; more...
    Cells (2021)

    Fulltext@MSK | Save
  • T cells critically depend on pyruvate oxidation
    Editorial

    Schrecker, C.; Intlekofer, A. M.
    Cell Metabolism (2021)

    Fulltext@MSK | Save
  • TET2 and DNMT3A mutations exert divergent effects on DNA repair and sensitivity of leukemia cells to PARP inhibitors
    Journal Article

    Maifrede, S.; Le, B. V.; Nieborowska-Skorska, M.; Golovine, K.; Sullivan-Reed, K.; Dunuwille, W. M. B.; Nacson, J.; Hulse, M.; Keith, K.; Madzo, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome
    Journal Article

    Herrera, A. F.; Ahn, K. W.; Litovich, C.; Chen, Y.; Assal, A.; Bashir, Q.; Bayer, R. L.; Coleman, M.; DeFilipp, Z.; Farhadfar, N.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Belantamab mafodotin (belamaf; GSK2857916) US expanded access program (EAP) for heavily pre-treated patients with relapsed/refractory multiple myeloma (RRMM): Baseline characteristics
    Meeting Abstract

    Hultcrantz, M.; Anderson, L. D. Jr; Anwer, F.; Gasparetto, C.; Kocoglu, M. H.; Lichtman, E. I.; Mo, C.; Niesvizky, R.; Lewis, E.; Li, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save